Drug Shortage Report for RABEPRAZOLE EC
| Report ID | 214284 |
| Drug Identification Number | 02356511 |
| Brand name | RABEPRAZOLE EC |
| Common or Proper name | RABEPRAZOLE SODIUM |
| Company Name | SANIS HEALTH INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RABEPRAZOLE SODIUM |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET (ENTERIC-COATED) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-12-22 |
| Estimated end date | 2024-07-26 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-05-08 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2023-12-26 | French | Compare |
| v1 | 2023-12-26 | English | Compare |